US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
July 13, 2022

US prevalence of optimal cardiometabolic health has declined as poor levels have risen significantly over 2 decades. Investigator Meghan O'Hearn, MS, details the research.

Insurance-mandated Weight Management Programs Prior to Bariatric Surgery Offer No Clinical Benefit
June 15, 2022

Insurance companies believe the required presurgical programs reduce complications and improve outcomes but a new study strongly suggests the opposite.

Antiobesity Medications May Support Long-term 10% Weight Loss, Suggests New Study
June 14, 2022

ENDO 2022: Findings from the long-term, real-world study of meds for maintenance of meaningful weight loss support wider uptake of the agents, authors say.

Kidney Outcomes with Tirzepatide in T2D: Hiddo Heerspink, PhD, PharmD Highlights SURPASS-4 Analysis
June 06, 2022

ADA 2022: Professor Hiddo Heerspink led the prespecified SURPASS-4 analysis that found tirzepatide associated with a 41% reduction in risk of a composite renal outcome.

Obesity and Depression in Adolescents: Understanding the Interplay
June 03, 2022

Understanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.

First-in-Class Tirzepatide Wins FDA Approval for Treatment of Type 2 Diabetes
May 16, 2022

Tirzepatide, a novel once-weekly GLP-1/GIP mimetic that binds to receptors and stimulates glucose-dependent insulin release, has shown superiority over many common antihyperglycemics.

Patient-centered Treatment for Obesity: Guidelines from the Canadian Obesity Society
May 12, 2022

The Canadian Obesity Society advocates for a therapeutic approach to obesity that removes stigma, focuses on individual patient goals, and favors body health over body weight.

Study: Only 3% of Adults with Overweight or Obesity in England are Referred to Weight Management Programs by Primary Care Clinician
May 09, 2022

Women, Black individuals, and adults diagnosed with overweight or obesity in more recent years were more likely to receive a referral, according to new study.

Obesity Rose Disproportionately Among Low-income Youth During Early COVID-19
May 09, 2022

The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.

Antiobesity Medication: An Effective Treatment Tool for the Right Patient
May 03, 2022

Obesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.